These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14621732)

  • 1. Cyclosporin A (CsA) and azathioprine (AZA) combination in renal allografts with CsA nephrotoxicity.
    Castelao AM; Griño JM; Sabate I; Seron D; Andres E; Gilvernet S; Bover J; Gonzalez C; Alsina J
    Transpl Int; 1992; 5 Suppl 1():S58-9. PubMed ID: 14621732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
    Gonwa T; Johnson C; Ahsan N; Alfrey EJ; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Leonhardt M; Fitzsimmons WE
    Transplantation; 2003 Jun; 75(12):2048-53. PubMed ID: 12829910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data.
    Joss N; Rodger RS; McMillan MA; Junor BJ
    Transplantation; 2007 Mar; 83(5):582-7. PubMed ID: 17353778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of a prospective randomized trial of conversion from cyclosporine to azathioprine treatment one year after renal transplantation.
    MacPhee IA; Bradley JA; Briggs JD; Junor BJ; MacPherson SG; McMillan MA; Rodger RS; Watson MA
    Transplantation; 1998 Nov; 66(9):1186-92. PubMed ID: 9825816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
    Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Mycophenolate Mofetil Acute Renal Rejection Study Group
    Transplantation; 2001 Apr; 71(8):1091-7. PubMed ID: 11374408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
    Clin Exp Nephrol; 2007 Jun; 11(2):151-155. PubMed ID: 17593515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of cadaveric renal transplant patients treated for 10 years with cyclosporine: is chronic allograft nephropathy the major cause of late graft loss?
    Marcén R; Pascual J; Teruel JL; Villafruela JJ; Rivera ME; Mampaso F; Burgos FJ; Ortuño J
    Transplantation; 2001 Jul; 72(1):57-62. PubMed ID: 11468535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Sutherland DE; Fryd DS; Strand MH; Canafax DM; Ascher NL; Payne WD; Simmons RL; Najarian JS
    Am J Kidney Dis; 1985 Jun; 5(6):318-27. PubMed ID: 3893106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
    Pham PT; Pham PC
    Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of the immunosuppressive protocol after lung transplantation.
    Reichenspurner H; Kur F; Treede H; Meiser BM; Deutsch O; Welz A; Vogelmeier C; Schwaiblmair M; Müller C; Fürst H; Briegel J; Reichart B
    Transplantation; 1999 Jul; 68(1):67-71. PubMed ID: 10428269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, prospective trial of cyclosporine monotherapy versus azathioprine-prednisone from three months after renal transplantation.
    Hilbrands LB; Hoitsma AJ; Koene KA
    Transplantation; 1996 Apr; 61(7):1038-46. PubMed ID: 8623182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term consequences of different immunosuppressive regimens for renal allografts.
    Isoniemi HM; Ahonen J; Tikkanen MJ; von Willebrand EO; Krogerus L; Eklund BH; Höckerstedt KV; Salmela KE; Häyry PJ
    Transplantation; 1993 Mar; 55(3):494-9. PubMed ID: 8456467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of rejection rates and kidney graft survival: a historical analysis.
    Marcén R; Fernández-Rodriguez A; Rodríguez-Mendiola N; Ponte B; Galeano C; Villafruela JJ; Teruel JL; Burgos FJ; Ortuño J
    Transplant Proc; 2009; 41(6):2357-9. PubMed ID: 19715918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of mycophenolate mofetil in patients with a transplanted kidney and cyclosporin nephrotoxicity].
    Hrvacević R; Ignjatović Lj; Vavić N; Dimitrijević J; Drasković-Pavlović B; Dujić A; Elaković D; Kronja G; Marić M
    Vojnosanit Pregl; 2001; 58(2):157-60. PubMed ID: 11475669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that addition of azathioprine improves renal function in cyclosporine-treated patients with allograft dysfunction.
    Pascual J; Marcén R; Orofino L; Quereda C; Mampaso F; Liaño F; Ortuño J
    Transplantation; 1991 Aug; 52(2):276-9. PubMed ID: 1871800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years.
    Johnson CP; Simmons RL; Sutherland DE; Canafax DM; Ascher NL; Payne WD; Flick B; Najarian JS; Fryd DS
    Transplantation; 1988 Feb; 45(2):380-5. PubMed ID: 3278431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients.
    Grimbert P; Baron C; Fruchaud G; Hemery F; Desvaux D; Buisson C; Chopin D; Dahmane D; Remy P; Pastural M; Abbou C; Weil B; Lang P
    Transpl Int; 2002 Nov; 15(11):550-5. PubMed ID: 12461659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful reversal of acute vascular rejection and cyclosporine-associated nephrotoxicity in renal allograft with combined sirolimus and mycophenolate mofetil as immunotherapy.
    Ołdakowska-Jedynak U; Paczek L; Mucha K; Foroncewicz B; Perkowska-Ptasińska A
    Transplant Proc; 2006; 38(1):66-8. PubMed ID: 16504666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.